ArticleBMC pediatrics2021

Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.

A M van Hulst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.